Persistent Wound Drainage among Total Joint Arthroplasty Patients Receiving Aspirin vs Coumadin

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000038524

Enrollment

Unknown

Registered

2020-09-23

Start date

2020-09-16

Completion date

Unknown

Last updated

2020-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Total Joint Arthroplasty

Interventions

aspirin:aspirin

Coumarin:Coumarin

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Primary total joint replacement; 2. Anticoagulation with aspirin or coumarin after surgery

Exclusion criteria

Exclusion criteria: 1. Joint infection or suspected infection; 2. Complicated with heart disease, deep vein thrombosis, coagulation dysfunction, history of joint surgery, etc.; 3. Liver and kidney dysfunction

Design outcomes

Primary

Measure	Time frame
Persistent wound drainage;Periprosthetic joint infections;Venous thromboembolism;	—

Contacts

Public ContactFeng Shuo

Affiliated Hospital of Xuzhou Medical University

xzfs0561@163.com+86 18552880088

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026